Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Enviga issue keeps burning

This article was originally published in The Tan Sheet

Executive Summary

While Coca-Cola and Nestle are touting a recent trial which finds their Enviga product burns more calories than it provides, the Center for Science in the Public Interest says the product actually had the exact opposite effect in some study participants. Six of the study's 31 participants burned 10% fewer calories after three days of consuming the green tea beverage, according to a Feb. 12 release from CSPI. Although Coca-Cola and Nestle claim the sparkling green tea beverage can burn 60 to 100 calories a day, CSPI senior nutritionist David Schardt asserts, "If you follow Coke's and Nestle's logic, then about one in five consumers will eventually get fatter" from the product. Separately, the Connecticut Attorney General Richard Blumenthal announces Feb. 5 his office is investigating claims for Enviga. Blumenthal's office has demanded copies of all scientific studies, clinical trials, tests and/or papers that support the calorie-burning claims by the week of Feb. 12. CSPI also filed a suit against Coke and Nestle Feb. 1 for its Enviga claims (1"The Tan Sheet," Feb. 5, 2007, In Brief)...

You may also be interested in...



FTC complaint filed over Enviga

The Center for Science in the Public Interest files a complaint with the Federal Trade Commission over weight-loss claims for Enviga May 21. "Enviga drinkers are being suckered into paying a premium for calorie-burning benefits they are not receiving," the complaint says. Coca-Cola/Nestle published a study to substantiate its product in February (1"The Tan Sheet" Feb. 19, 2007, In Brief). However, the study consisted of 31 lean subjects and lasted 72 hours. CSPI also filed suit against the companies in February in the U.S. District Court for the District of New Jersey (2"The Tan Sheet" Feb. 5, 2007, In Brief). The consumer group urges FTC to enjoin the companies from making further weight-loss claims regarding Enviga as well as to require a monetary penalty and corrective advertising. Coca-Cola and Nestle launched Enviga nationwide in January (3"The Tan Sheet" Oct. 23, 2006, p. 11)...

Enviga claims challenged in suit

The Center for Science in the Public Interests files suit against Coke and Nestle Feb. 1 in the U.S. District Court for the District of New Jersey, charging the firms make "fraudulent" claims in marketing and labeling for its Enviga "calorie-burning" diet green tea beverage. Specific claims the watchdog group targets include Enviga's "negative calories" claim and claims that drinking the green tea-flavored drink is "much smarter" than following other quick dieting techniques. "According to CSPI scientists who reviewed the studies cited by Coke and Nestle, Enviga is just a highly caffeinated and over-priced diet soda, and is exactly the kind of faddy, phony diet aid it claims not to be," CSPI states in a release. The firms launched Enviga in November 2006 (1"The Tan Sheet" Oct. 23, 2006, p. 11)...

Biogen Sees Improving Momentum In Slow Leqembi Launch

Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100225

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel